FAES FARMA, S.A.

Analyst Reco. Faes Farma, S.A.

Equities

FAE

ES0134950F36

Market Closed - BME Other stock markets 11:35:10 2024-04-30 am EDT			After market 03:59:00 pm
3.405 ^EUR	+0.74%		3.39	-0.44%

Apr. 26	FAES FARMA : Q1 beat; full-year guidance re-affirmed
Feb. 27	FAES FARMA : Q4 profitability exceeded expectations

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FAES FARMA : Q1 beat; full-year guidance re-affirmed	Apr. 26
FAES FARMA : Q4 profitability exceeded expectations	Feb. 27
FAES FARMA : Mixed Q3; markets need more from Faes to be convinced	23-10-25
FAES FARMA : A soft Q2, as expected; guidance maintained	23-08-01
FAES FARMA : Increased R&D focus and inflationary pressures to hold back near-to-medium term earnings	23-07-12
FAES FARMA : A healthy start to 2023	23-05-08
FAES FARMA : 2022 guidance met + positive view maintained	23-03-06
Roche’s Alzheimer’s failure has sector-wide implications	22-11-14
FAES FARMA : Soft Q3, but 2022 guidance maintained	22-10-28
FAES FARMA : Another stronger quarter but maintained full-year outlook	22-08-01
FAES FARMA : Strong Q1; but some moderation lies ahead	22-05-02
FAES FARMA : A strong Q4 sums up a decent 2021	22-03-02
FAES FARMA : An overall strong Q3	21-11-02
FAES FARMA : Base business recovers in Q2; FY21 outlook reiterated despite resurfacing COVID-19 concerns	21-07-28
TODAY'S ANALYST RECOMMENDATIONS : Cisco, easyJet, L Brands, Mattel, Salesforce...	21-05-21
FAES FARMA : Q1 21 – a mixed bag	21-05-04
FAES FARMA : Bilastine weighed on FY20; capacity expansion to cater underlying demand	21-03-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Faes Farma: Q1 beat; full-year guidance re-affirmed

FAES FARMA : Q1 beat; full-year guidance re-affirmed

April 26, 2024 at 11:34 am EDT

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer